Continuing in the spirit of innovation through collaboration, we are pleased to invite you to the second Personalizing Pediatric Cancer Care summit, cohosted by UCSF Benioff Children’s Hospitals and Children’s Hospital of Philadelphia. Join us for an enlightening exploration of the latest advances in precision medicine and how they are reshaping the landscape of pediatric cancer care, research and precision-based oncology. CME credits will be available.

Join other physicians, care providers, clinical geneticists, laboratory leaders and researchers to learn about the latest developments, including:

• Hematological malignancies
• CNS malignancies
• Solid malignancies
• Cancer predisposition
• Advances in lab diagnostics and genetics
• FDA/regulatory upda

Objectives

• Articulate the significance of recent advances in liquid biopsies, demonstrating their application in measuring minimal residual disease and early detection of relapse.
• Investigate and appraise new therapeutic opportunities for patients in the relapsed setting using next-generation sequencing panels, while critically assessing the limitations of this technology.
• Analyze and differentiate the frequency and diversity of germline alterations relevant to cancer diagnosis in children and young adults.
• Apply knowledge of germline alterations to implement precise screening practices for patients with cancer and their families.
• Evaluate and address current barriers impeding the widespread use of immunotherapy in pediatric cancer.
• Recognize and assess the emerging importance of CART and other cell therapies in pediatric cancer.

Target audience

• Physicians, Nurse Practitioners, Physician Assistants, Nurses, Clinical Geneticists, PhD Researchers, Laboratory Professionals

Registration

• Learn more and register to attend